US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist

3.320
+0.170+5.40%

Close Nov 27 16:00 ET

3.130
-0.190-5.72%

Post 19:54 ET

141.14MMarket Cap-1668P/E (TTM)

Repare Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

7.09%-30.54M

11.16%-30.51M

137.54%11.93M

-39,590.06%-127.16M

5.00%-28.16M

-137.29%-32.87M

-21.82%-34.35M

-5.93%-31.79M

100.38%322K

-42.91%-29.64M

Net income from continuing operations

-82.24%-34.41M

-191.09%-34.77M

137.67%13.16M

-222.91%-93.8M

11.46%-28.03M

-125.02%-18.88M

68.64%-11.95M

-0.53%-34.94M

72.83%-29.05M

-11.91%-31.66M

Operating gains losses

-172.73%-8K

16.67%-5K

-133.33%-22K

126.17%78K

110.29%7K

111.70%11K

93.75%-6K

265.00%66K

-927.78%-298K

-361.54%-68K

Depreciation and amortization

-4.02%478K

-3.56%488K

13.61%501K

-1.37%1.95M

11.21%506K

2.89%498K

-3.25%506K

-14.53%441K

34.47%1.98M

23.64%455K

Other non cash items

23.23%679K

4.22%568K

4.07%563K

-0.54%2.19M

-1.07%557K

-0.18%551K

-0.37%545K

-0.55%541K

17.78%2.21M

-9.92%563K

Change In working capital

94.17%-1.14M

94.04%-1.65M

-254.54%-7.5M

-787.64%-55.18M

8.17%-5.9M

-324.24%-19.55M

-605.69%-27.62M

-883.70%-2.12M

67.54%8.03M

-645.33%-6.42M

-Change in receivables

-113.31%-604K

159.77%740K

140.50%1.11M

84.40%-216K

-108.23%-775K

143.60%4.54M

-8,353.33%-1.24M

-578.47%-2.74M

-146.20%-1.39M

7,020.59%9.41M

-Change in prepaid assets

28.13%-971K

-1,328.72%-2.31M

-3.31%1.29M

63.41%969K

1,066.27%802K

43.61%-1.35M

-72.07%188K

-44.56%1.33M

1,953.13%593K

-103.47%-83K

-Change in payables and accrued expense

104.50%902K

-47.03%1.58M

3.15%1.47M

-517.87%-9.98M

352.33%5.64M

-22,925.29%-20.03M

-46.94%2.98M

256.69%1.43M

-79.79%2.39M

-132.74%-2.23M

-Change in other current assets

945.45%115K

--0

0.00%89K

13.48%101K

--1K

--11K

--0

--89K

129.87%89K

--0

-Change in other current liabilities

-5.05%-582K

-5.42%-584K

-6.59%-582K

-45.13%-2.22M

-43.80%-568K

-17.12%-554K

-114.73%-554K

-34.81%-546K

-50.10%-1.53M

-50.76%-395K

-Change in other working capital

--0

96.30%-1.07M

-548.72%-10.88M

-656.95%-43.83M

16.21%-11M

-109.78%-2.16M

-4,170.99%-29M

-311.03%-1.68M

190.66%7.87M

-64.92%-13.12M

Cash from discontinued investing activities

Operating cash flow

7.09%-30.54M

11.16%-30.51M

137.54%11.93M

-39,590.06%-127.16M

5.00%-28.16M

-137.29%-32.87M

-21.82%-34.35M

-5.93%-31.79M

100.38%322K

-42.91%-29.64M

Investing cash flow

Cash flow from continuing investing activities

26.87%31.08M

-74.89%7.12M

-203.86%-20.32M

144.40%78.04M

-6.40%31.88M

111.73%24.5M

2,265.78%28.35M

-1,759.06%-6.69M

-10,387.95%-175.78M

8,657.29%34.06M

Net PPE purchase and sale

--0

-221.93%-1.94M

-123.14%-398K

--0

32.12%-1.07M

2.46%-475K

63.52%-602K

1,476.00%1.72M

Net investment purchase and sale

26.87%31.08M

-75.80%7.12M

-227.10%-20.32M

145.66%79.98M

-0.19%32.28M

111.74%24.5M

11,213.46%29.42M

-797.87%-6.21M

-673,653.85%-175.18M

11,945.42%32.34M

Cash from discontinued investing activities

Investing cash flow

26.87%31.08M

-74.89%7.12M

-203.86%-20.32M

144.40%78.04M

-6.40%31.88M

111.73%24.5M

2,265.78%28.35M

-1,759.06%-6.69M

-10,387.95%-175.78M

8,657.29%34.06M

Financing cash flow

Cash flow from continuing financing activities

-41.55%166K

-9.20%375K

-4.32%842K

-36.36%105K

5.58%284K

-80.49%40K

71.37%413K

-99.08%880K

-99.83%165K

Proceeds from stock option exercised by employees

-41.55%166K

--0

-9.20%375K

-4.32%842K

-36.36%105K

5.58%284K

-80.49%40K

71.37%413K

-30.65%880K

-39.78%165K

Cash from discontinued financing activities

Financing cash flow

-41.55%166K

--0

-9.20%375K

-4.32%842K

-36.36%105K

5.58%284K

-80.49%40K

71.37%413K

-99.08%880K

-99.83%165K

Net cash flow

Beginning cash position

-30.92%79.82M

-15.02%103.22M

-30.25%111.27M

-52.30%159.52M

-30.81%107.37M

-58.11%115.54M

-60.19%121.46M

-52.30%159.52M

2.46%334.43M

-40.54%155.19M

Current changes in cash

108.74%707K

-292.81%-23.4M

78.96%-8.01M

72.35%-48.28M

-16.53%3.83M

93.29%-8.09M

79.67%-5.96M

-29.62%-38.06M

-2,259.26%-174.58M

-93.75%4.59M

Effect of exchange rate changes

116.09%14K

-102.56%-1K

-4,100.00%-42K

106.67%22K

127.73%71K

37.86%-87K

880.00%39K

-101.41%-1K

-511.11%-330K

-4,366.67%-256K

End cash Position

-24.99%80.54M

-30.92%79.82M

-15.02%103.22M

-30.25%111.27M

-30.81%107.37M

-58.11%115.54M

-60.19%121.46M

-52.30%159.52M

Free cash flow

7.09%-30.54M

13.83%-30.51M

136.99%11.93M

-46,005.71%-129.1M

-2.28%-28.55M

-137.40%-32.87M

-18.98%-35.41M

-5.80%-32.26M

99.68%-280K

-33.55%-27.92M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	7.09%-30.54M	11.16%-30.51M	137.54%11.93M	-39,590.06%-127.16M	5.00%-28.16M	-137.29%-32.87M	-21.82%-34.35M	-5.93%-31.79M	100.38%322K	-42.91%-29.64M
Net income from continuing operations	-82.24%-34.41M	-191.09%-34.77M	137.67%13.16M	-222.91%-93.8M	11.46%-28.03M	-125.02%-18.88M	68.64%-11.95M	-0.53%-34.94M	72.83%-29.05M	-11.91%-31.66M
Operating gains losses	-172.73%-8K	16.67%-5K	-133.33%-22K	126.17%78K	110.29%7K	111.70%11K	93.75%-6K	265.00%66K	-927.78%-298K	-361.54%-68K
Depreciation and amortization	-4.02%478K	-3.56%488K	13.61%501K	-1.37%1.95M	11.21%506K	2.89%498K	-3.25%506K	-14.53%441K	34.47%1.98M	23.64%455K
Other non cash items	23.23%679K	4.22%568K	4.07%563K	-0.54%2.19M	-1.07%557K	-0.18%551K	-0.37%545K	-0.55%541K	17.78%2.21M	-9.92%563K
Change In working capital	94.17%-1.14M	94.04%-1.65M	-254.54%-7.5M	-787.64%-55.18M	8.17%-5.9M	-324.24%-19.55M	-605.69%-27.62M	-883.70%-2.12M	67.54%8.03M	-645.33%-6.42M
-Change in receivables	-113.31%-604K	159.77%740K	140.50%1.11M	84.40%-216K	-108.23%-775K	143.60%4.54M	-8,353.33%-1.24M	-578.47%-2.74M	-146.20%-1.39M	7,020.59%9.41M
-Change in prepaid assets	28.13%-971K	-1,328.72%-2.31M	-3.31%1.29M	63.41%969K	1,066.27%802K	43.61%-1.35M	-72.07%188K	-44.56%1.33M	1,953.13%593K	-103.47%-83K
-Change in payables and accrued expense	104.50%902K	-47.03%1.58M	3.15%1.47M	-517.87%-9.98M	352.33%5.64M	-22,925.29%-20.03M	-46.94%2.98M	256.69%1.43M	-79.79%2.39M	-132.74%-2.23M
-Change in other current assets	945.45%115K	--0	0.00%89K	13.48%101K	--1K	--11K	--0	--89K	129.87%89K	--0
-Change in other current liabilities	-5.05%-582K	-5.42%-584K	-6.59%-582K	-45.13%-2.22M	-43.80%-568K	-17.12%-554K	-114.73%-554K	-34.81%-546K	-50.10%-1.53M	-50.76%-395K
-Change in other working capital	--0	96.30%-1.07M	-548.72%-10.88M	-656.95%-43.83M	16.21%-11M	-109.78%-2.16M	-4,170.99%-29M	-311.03%-1.68M	190.66%7.87M	-64.92%-13.12M
Cash from discontinued investing activities
Operating cash flow	7.09%-30.54M	11.16%-30.51M	137.54%11.93M	-39,590.06%-127.16M	5.00%-28.16M	-137.29%-32.87M	-21.82%-34.35M	-5.93%-31.79M	100.38%322K	-42.91%-29.64M
Investing cash flow
Cash flow from continuing investing activities	26.87%31.08M	-74.89%7.12M	-203.86%-20.32M	144.40%78.04M	-6.40%31.88M	111.73%24.5M	2,265.78%28.35M	-1,759.06%-6.69M	-10,387.95%-175.78M	8,657.29%34.06M
Net PPE purchase and sale	--0	--0	--0	-221.93%-1.94M	-123.14%-398K	--0	32.12%-1.07M	2.46%-475K	63.52%-602K	1,476.00%1.72M
Net investment purchase and sale	26.87%31.08M	-75.80%7.12M	-227.10%-20.32M	145.66%79.98M	-0.19%32.28M	111.74%24.5M	11,213.46%29.42M	-797.87%-6.21M	-673,653.85%-175.18M	11,945.42%32.34M
Cash from discontinued investing activities
Investing cash flow	26.87%31.08M	-74.89%7.12M	-203.86%-20.32M	144.40%78.04M	-6.40%31.88M	111.73%24.5M	2,265.78%28.35M	-1,759.06%-6.69M	-10,387.95%-175.78M	8,657.29%34.06M
Financing cash flow
Cash flow from continuing financing activities	-41.55%166K	0	-9.20%375K	-4.32%842K	-36.36%105K	5.58%284K	-80.49%40K	71.37%413K	-99.08%880K	-99.83%165K
Proceeds from stock option exercised by employees	-41.55%166K	--0	-9.20%375K	-4.32%842K	-36.36%105K	5.58%284K	-80.49%40K	71.37%413K	-30.65%880K	-39.78%165K
Cash from discontinued financing activities
Financing cash flow	-41.55%166K	--0	-9.20%375K	-4.32%842K	-36.36%105K	5.58%284K	-80.49%40K	71.37%413K	-99.08%880K	-99.83%165K
Net cash flow
Beginning cash position	-30.92%79.82M	-15.02%103.22M	-30.25%111.27M	-52.30%159.52M	-30.81%107.37M	-58.11%115.54M	-60.19%121.46M	-52.30%159.52M	2.46%334.43M	-40.54%155.19M
Current changes in cash	108.74%707K	-292.81%-23.4M	78.96%-8.01M	72.35%-48.28M	-16.53%3.83M	93.29%-8.09M	79.67%-5.96M	-29.62%-38.06M	-2,259.26%-174.58M	-93.75%4.59M
Effect of exchange rate changes	116.09%14K	-102.56%-1K	-4,100.00%-42K	106.67%22K	127.73%71K	37.86%-87K	880.00%39K	-101.41%-1K	-511.11%-330K	-4,366.67%-256K
End cash Position	-24.99%80.54M	-30.92%79.82M	-15.02%103.22M	-30.25%111.27M	-30.25%111.27M	-30.81%107.37M	-58.11%115.54M	-60.19%121.46M	-52.30%159.52M	-52.30%159.52M
Free cash flow	7.09%-30.54M	13.83%-30.51M	136.99%11.93M	-46,005.71%-129.1M	-2.28%-28.55M	-137.40%-32.87M	-18.98%-35.41M	-5.80%-32.26M	99.68%-280K	-33.55%-27.92M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data